Inhibition of tumor angiogenesis and melanoma growth by targeting vascular E-selectin

Annals of Surgery

Volumn 254, Issue 3, 2011, Pages 450-457

  Liu, Zhao Jun ^a,b   Tian, Runxia ^a   Li, Yan ^a   An, Weijun ^a   Zhuge, Ying ^a   Livingstone, Alan S ^a   Velazquez, Omaida C ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; LENTIVIRUS VECTOR; SC 29296; SMALL INTERFERING RNA; STROMAL CELL DERIVED FACTOR 1ALPHA; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANGIOGENIC GENE THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER GROWTH; CANCER INHIBITION; CELL ASSAY; CELL GROWTH; CELL HOMING; CELL PROLIFERATION; CONFERENCE PAPER; CONFOCAL LASER MICROSCOPY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LASER; MELANOMA; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; SEVERE COMBINED IMMUNODEFICIENCY; TUMOR VASCULARIZATION; TUMOR VOLUME; TUMOR XENOGRAFT; VALIDATION PROCESS; VIRAL GENE DELIVERY SYSTEM; CANCER SIZE; IN VITRO STUDY; IN VIVO STUDY; PROTEIN EXPRESSION; STEM CELL; UPREGULATION;

ANIMALS; CHEMOKINE CXCL12; DOWN-REGULATION; E-SELECTIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MELANOMA, EXPERIMENTAL; MICE; MICE, SCID; NEOVASCULARIZATION, PATHOLOGIC; RNA, SMALL INTERFERING; TRANSPLANTATION, HETEROLOGOUS; TREATMENT OUTCOME; UP-REGULATION;

EID: 80052277433     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31822a72dc     Document Type: Conference Paper

References (30)

1. Naumov GN, Akslen LA, Folkman J. Role of angiogenesis in human tumor dormancy: animal models of the angiogenic switch. Cell Cycle. 2006;5:1779-1787. (Pubitemid 44435320)
2. Lapidot T. Mechanism of human stem cell migration and repopulation of NOD/SCID and B2mnull NOD/SCID mice. The role of SDF-1/CXCR4 interactions. Ann N Y Acad Sci. 2001;938:83-95. (Pubitemid 32620021)
3. Petit I, Jin D, Rafii S. The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis. Trends Immunol. 2007;28:299-307. (Pubitemid 46963141)
4. Li M, Ransohoff RM. The roles of chemokine CXCL12 in embryonic and brain tumor angiogenesis. Semin Cancer Biol. 2009;19:111-115.
5. OrimoA,Weinberg RA. Stromal fibroblasts in cancer: a novel tumor-promoting cell type. Cell Cycle. 2006;5:1597-1601. (Pubitemid 44285243)
6. Muller WA. Leukocyte-endothelial cell interactions in the inflammatory response. Lab Invest. 2002;82:521-533. (Pubitemid 34522364)
7. Allinen M, Beroukhim R, Cai L, et al.Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell. 2004;6:17-32. (Pubitemid 38903159)
8. Liu ZJ, Zhuge Y, Velazquez OC. Trafficking and differentiation of mesenchymal stem cells. J Cell Biochem. 2009;106:984-991.
9. Sanchez-Martin L, Estecha A, Samaniego R, et al. The chemokine CXCL12 regulates monocyte-macrophage differentiation and RUNX3 expression. Blood. 2010;117:88-97.
10. Walter DH, Haendeler J, Reinhold J, et al. Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patientswith coronary artery disease. Circ Res. 2005;97:1142-1151.
11. Abbott JD, Huang Y, Liu D, et al. Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation. 2004;110:3300-3305. (Pubitemid 39557491)
12. Liu ZJ, Tian R, An W, et al. Identification of E-selectin as a novel target for the regulation of postnatal neovascularization: implications for diabetic wound healing. Ann Surg. 2010;252:625-634.
13. Balint K, Xiao M, Pinnix CC, et al. Activation of Notch1 signaling is required for beta-catenin-mediated human primarymelanoma progression. J Clin Invest. 2005;115:3166-3176. (Pubitemid 41567581)
14. Song E, Lee SK, Wang J, et al. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med. 2003;9:347-351. (Pubitemid 36362792)
15. Oh IY, Yoon CH, Hur J, et al. Involvement of E-selectin in recruitment of endothelial progenitor cells and angiogenesis in ischemic muscle. Blood. 2007;110:3891-3899. (Pubitemid 350248444)
16. Li Y, Song Y, Zhao L, et al. Direct labeling and visualization of blood vessels with lipophilic carbocyanine dye DiI. Nat Protoc. 2008;3:1703-1708.
17. Laubli H, Borsig L. Selectins promote tumor metastasis. Semin Cancer Biol. 2010;20:169-177.
18. Witz IP. The selectin-selectin ligand axis in tumor progression. Cancer Metastasis Rev. 2008;27:19-30.
19. Kannagi R. Molecular mechanism for cancer-associated induction of sialyl LewisXand sialyl LewisAexpression-TheWarburg effect revisited. Glycoconj J. 2004;20:353-364. (Pubitemid 39024043)
20. Gout S, Tremblay PL, Huot J. Selectins and selectin ligands in extravasation of cancer cells and organ selectivity of metastasis. Clin Exp Metastasis. 2008;25:335-344. (Pubitemid 351752950)
21. Burdick MM, McCaffery JM, Kim YS, et al. Colon carcinoma cell glycolipids, integrins, and other glycoproteins mediate adhesion to HUVECs under flow. Am J Physiol Cell Physiol. 2003;284:C977-987. (Pubitemid 36336954)
22. Mannori G, Santoro D, Carter L, et al. Inhibition of colon carcinoma cell lung colony formation by a soluble form of E-selectin. Am J Pathol. 1997;151:233-243. (Pubitemid 27283974)
23. Fukuda MN, Ohyama C, Lowitz K, et al. A peptide mimic of E-selectin ligand inhibits sialyl Lewis X-dependent lung colonization of tumor cells. Cancer Res. 2000;60:450-456. (Pubitemid 30070775)
24. Barthel SR, Wiese GK, Cho J, et al. Alpha 1,3 fucosyltransferases are master regulators of prostate cancer cell trafficking. Proc Natl Acad Sci USA. 2009;106:19491-19496.
25. Mannori G, Crottet P, Cecconi O, et al. Differential colon cancer cell adhesion to E-, P-, and L-selectin: role of mucin-type glycoproteins. Cancer Res. 1995;55:4425-4431.
26. Burdick MM, Chu JT, Godar S, et al. HCELL is the major E-and Lselectin ligand expressed on LS174T colon carcinoma cells. J Biol Chem. 2006;281:13899-13905. (Pubitemid 43848314)
27. Gout S, Morin C, Houle F, et al. Death receptor-3, a new E-Selectin counterreceptor that confers migration and survival advantages to colon carcinoma cells by triggering p38 and ERKMAPKactivation. Cancer Res. 2006;66:9117-9124. (Pubitemid 44521131)
28. Aychek T, Miller K, Sagi-Assif O, et al. E-selectin regulates gene expression in metastatic colorectal carcinoma cells and enhances HMGB1 release. Int J Cancer. 2008;123:1741-1750.
29. Kansas GS. Selectins and their ligands: current concepts and controversies. Blood. 1996;88:3259-3287. (Pubitemid 26365560)
30. McEver RP. Selectins: lectins that initiate cell adhesion under flow. Curr Opin Cell Biol. 2002;14:581-586. (Pubitemid 35247741)